Evidence map›Paper›PMID 36540907›Full record

ArticleStatistical methods in medical research2023

A reference-free R-learner for treatment recommendation.

Junyi Zhou, Ying Zhang, Wanzhu Tu

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junyi ZhouDesign and Inovation, 7129Amgen Inc., Thousand Oaks, CA, USA.ORCID 0000-0003-4493-6997
Ying ZhangDepartment of Biostatistics, 12284University of Nebraska Medical Center, Omaha, NE, USA.ORCID 0000-0002-9680-8981
Wanzhu TuDepartment of Biostatistics and Health Data Science, Indiana University-School of Medicine and Fairbanks School of Public Health, Indianapolis, IN, USA.ORCID 0000-0002-4236-9135

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GUDA, CHITTIBABU · 2016 to 2025
$42.8M
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Indiana University Data Coordinating CenterU24AA026969 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI SAMER GAWRIEH, WANZHU TU · 2018 to 2026
$20.2M
Research Design, Compliance and Data Management CoreP50GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Matthew Rizzo · 2026 to 2026
$10.2M
Novel biomarkers as a clinical tool for excessive alcohol use screeningR01AA025208 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT, TU, WANZHU · 2016 to 2020
$1.7M
Effects of Somatic Growth and Sodium Retention on Blood PressureR01HL095086 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI PRATT, JOHN HOWARD, TU, WANZHU · 2009 to 2012
$1.5M
NHLBI NIH HHS R01 HL095086NIAAA NIH HHS R01 AA025208NIAAA NIH HHS U24 AA026969NIGMS NIH HHS P50 GM115458NIGMS NIH HHS U54 GM115458
6 · The paper itself

Abstract

Assigning optimal treatments to individual patients based on their characteristics is the ultimate goal of precision medicine. Deriving evidence-based recommendations from observational data while considering the causal treatment effects and patient heterogeneity is a challenging task, especially in situations of multiple treatment options. Herein, we propose a reference-free R-learner based on a simplex algorithm for treatment recommendation. We showed through extensive simulation that the proposed method produced accurate recommendations that corresponded to optimal treatment outcomes, regardless of the reference group. We used the method to analyze data from the Systolic Blood Pressure Intervention Trial (SPRINT) and achieved recommendations consistent with the current clinical guidelines.

Indexed as

Precision MedicineBlood PressureCausalityClinical Trials as TopicComputer SimulationHumansTreatment OutcomeHeterogeneous treatment effectR-learnersimplextreatment recommendation

Identifiers

PMID36540907
PMCPMC11376343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.